This article explores the presence of tryptamines classified as NPS among the substances delivered for analysis to a harm-reduction organization, to describe the substances found in the samples after analysis, and to compare analytical results of regulated vs. non-regulated tryptamines. It argues that there is a need for further research in order to prevent the potential health risks associated with their use.
ResearchTags
2C-C
4-FA
4-FMP
25C-NBOMe
adulteration
Alert
alprazolam
amantadine
antihistamine mixture
benzodiacepine
cryptomarkets
cyproheptadine
deep web
DMT
doxepin
drug checking service
drug testing
ecstasy
Encryption
ephylone
Etizolam
fentanyl
fentanyl derivatives
festival
flualprazolam
flubromazolam
GPG
harm reduction
heroin
International Energy Control
intoxication
LSD
mail
MDMA
methamphetamine
mushroom
N-Ethyl-Pentylone
NBOME
NPS
pills
poisoning
promethazine
U-47700
U-49900
xanax
Recent posts
- Important update about GPG 4 October, 2022
- Important information about shipments 24 December, 2021
- Recent Adware Attack on site 16 December, 2020
- Back in Business & Overhaul 4 June, 2020
- Drug Crypto Markets at CND63 27 March, 2020
- Update regarding COVID-19 23 March, 2020